Species-dependent effect of neuromuscular blocking agents.
D000731:Androstanes / Q000494:pharmacology; D000818:Animals; D002415:Cats; D003650:Decamethonium Compounds / Q000494:pharmacology; D005260:Female; D005703:Gallamine Triethiodide / Q000494:pharmacology; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects*; D009467:Neuromuscular Depolarizing Agents / Q000494:pharmacology*; D009469:Neuromuscular Junction / Q000187:drug effects; D010880:Piperidines / Q000494:pharmacology; D011759:Pyrrolidines / Q000494:pharmacology; D051381:Rats; D013045:Species Specificity; D013390:Succinylcholine / Q000494:pharmacology; D013977:Tibia; D014117:Toxiferine / Q000494:pharmacology; D014403:Tubocurarine / Q000494:pharmacology
D000731:Androstanes; D003650:Decamethonium Compounds; D009467:Neuromuscular Depolarizing Agents; D010880:Piperidines; D011759:Pyrrolidines; D014117:Toxiferine; D013390:Succinylcholine; D005703:Gallamine Triethiodide; D014403:Tubocurarine